Inventor · disambiguated record
Youssef El-Ahmad
Also filed as: EL-AHMAD YOUSSEF
23 granted patents·15 pending applications·218 citations·filing 2001–2025
95Inventor score
Top patents by PatentIndex Score
38 records- 0196US11214541B2Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2020·Granted Jan 4, 2022·7 cites·20 claims
- 0296US9714221B1Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2017·Granted Jul 25, 2017·18 cites·17 claims
- 0395US10570090B2Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2017·Granted Feb 25, 2020·10 cites·24 claims
- 0494US6603005B2Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted Aug 5, 2003·45 cites·20 claims
- 0593US6903217B2Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing themAVENTIS PHARMA SA·Filed 2003·Granted Jun 7, 2005·37 cites·15 claims
- 0691US11149031B2Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2019·Granted Oct 19, 2021·6 cites·16 claims
- 0786US7935819B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2008·Granted May 3, 2011·15 cites·12 claims
- 0886US7354933B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2004·Granted Apr 8, 2008·27 cites·58 claims
- 0985US7902219B22-benzoylimidazopyridine derivatives, preparation and therapeutic use thereofSANOFI AVENTIS·Filed 2008·Granted Mar 8, 2011·8 cites·8 claims
- 1085US7560571B2Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereofAVENTIS PHARMA SA·Filed 2007·Granted Jul 14, 2009·5 cites·19 claims
- 1185US2024150284A1Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2023·Application pending·0 cites
- 1284US7528147B2Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitorsAVENTIS PHARMA SA·Filed 2006·Granted May 5, 2009·8 cites·42 claims
- 1382US7704989B2Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeuticsSANOFI AVENTIS·Filed 2008·Granted Apr 27, 2010·7 cites·8 claims
- 1482US7232833B24-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing themNOVEXEL·Filed 2004·Granted Jun 19, 2007·14 cites·16 claims
- 1580US2025368605A1Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2025·Application pending·0 cites
- 1678US2022073460A1Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2021·Application pending·0 cites
- 1772US8048893B2Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2009·Granted Nov 1, 2011·1 cites·17 claims
- 1872US2020392081A1Novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2020·Application pending·0 cites
- 1971US7825115B2Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2008·Granted Nov 2, 2010·1 cites·56 claims
- 2069US7759379B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2007·Granted Jul 20, 2010·1 cites·18 claims
- 2169US7524838B2Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2004·Granted Apr 28, 2009·4 cites·7 claims
- 2266US9321790B2Pyrimidinone derivatives as antimalarial agentsSANOFI SA·Filed 2013·Granted Apr 26, 2016·2 cites·23 claims
- 2364US2022204488A1Novel Substituted N-(3-Fluoropropyl)-Pyrrolidine Compounds, Processes for their Preparation and Therapeutic Uses ThereofSANOFI SA·Filed 2021·Application pending·0 cites
- 2463US2025368619A1Substituted tetrahydrocyclohepta[e]indole derivatives, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 2562US2025262186A1Novel substituted fluorinated n-propyl-pyrrolidine and n-propyl-azetidine compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 2661US11739100B22,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereofSANOFI SA·Filed 2019·Granted Aug 29, 2023·0 cites·13 claims
- 2761US2025255848A1Substituted 6,7-dihydro-5h-benzo[7]annulene derivatives, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 2861US2025263390A1Novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 2961US2025250261A1Novel substituted fluorinated vinyl-n-propyl-pyrrolidine compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 3061US2025250231A1Novel substituted 4-amino-4-oxo-but-2-enyl derivatives, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 3159US7968566B2Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitorsAVENTIS PHARMA SA·Filed 2009·Granted Jun 28, 2011·0 cites·8 claims
- 3257US2025248970A1Novel substituted fluorinated n-propyl-pyrrolidine compounds, processes for their preparation and therapeutic uses thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 3355US7786114B2Bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2007·Granted Aug 31, 2010·0 cites·6 claims
- 3455US7396934B2Process for preparing 3-fluoroquinolinesEL-AHMAD YOUSSEF·Filed 2004·Granted Jul 8, 2008·2 cites·16 claims
- 3550US10253043B22,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereofSANOFI SA·Filed 2013·Granted Apr 9, 2019·0 cites·14 claims
- 3647US2009082329A1Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase InhibitorsAVENTIS PHARMA SA·Filed 2008·Application pending·0 cites
- 3745US2008021029A1Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase InhibitorsAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 3843US2010256141A1Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Youssef El-Ahmad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →